Hanna John Walter JR 4

Accession 0001437749-20-019131

CIK 0001384101other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 5:08 PM ET

Size

27.8 KB

Accession

0001437749-20-019131

Form 4

Period: 2020-08-31

Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
2020-08-31$9.05/sh+9,375$84,844→ 121,233 total
Exercise/Conversion
Common Stock
2020-08-31$5.98/sh+9,844$58,867→ 131,077 total
Exercise/Conversion
Stock Option (right to buy)
2020-08-31−53→ 0 total
Exercise: $4.00Exp: 2023-02-04→ Common Stock (53 underlying)
Exercise/Conversion
Stock Option (right to buy)
2020-08-31−8,835→ 2 total
Exercise: $8.86Exp: 2025-03-01→ Common Stock (8,835 underlying)
Exercise/Conversion
Stock Option (right to buy)
2020-08-31−19,336→ 2 total
Exercise: $6.45Exp: 2026-02-28→ Common Stock (19,336 underlying)
Exercise/Conversion
Common Stock
2020-08-31$14.34/sh+9,000$129,060→ 83,687 total
Exercise/Conversion
Stock Option (right to buy)
2020-08-31−9,000→ 0 total
Exercise: $14.34Exp: 2024-02-18→ Common Stock (9,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2020-08-31−9,375→ 10,417 total
Exercise: $9.05Exp: 2027-03-02→ Common Stock (9,375 underlying)
Exercise/Conversion
Common Stock
2020-08-31$6.45/sh+19,336$124,717→ 111,858 total
Exercise/Conversion
Stock Option (right to buy)
2020-08-31−9,844→ 24,063 total
Exercise: $5.98Exp: 2028-03-01→ Common Stock (9,844 underlying)
Exercise/Conversion
Common Stock
2020-08-31$4.00/sh+53$212→ 74,687 total
Exercise/Conversion
Common Stock
2020-08-31$8.86/sh+8,835$78,278→ 92,522 total
Sale
Common Stock
2020-08-31$33.37/sh−55,970$1,867,573→ 75,107 total
Sale
Common Stock
2020-08-31$33.78/sh−473$15,976→ 74,634 total

Footnotes (6)

[F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020.
[F2]Represents weighted average sales price. Sale prices for the transactions range from $32.72 to $33.71. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
[F3]Represents weighted average sales price. Sale prices for the transactions range from $33.77 to $33.81. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
[F4]The option is fully vested.
[F5]The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
[F6]The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

Documents

1 file

VERACYTE, INC.

CIK 0001384101

Entity typeother